Depression - the first symptom of a brain tumor or a consequence of the process neoplastic process - a review of the literature
DOI:
https://doi.org/10.12775/JEHS.2023.46.01.016Keywords
brain tumor, glioblastoma multiforme, depression, cognitive impairment, cancerAbstract
Introduction and objective
CNS malignancies account for about 1.6% of all diseases today. In people diagnosed with a
brain tumor with a poor prognosis, we often see disorders from the psychiatric spectrum,
most often depressive disorders. In this paper, we want to focus on whether depression occurs
as a sequel to cancer or perhaps is the first of the symptoms of a CNS tumor.
Review methods
For the analysis, the PubMed medical database was searched, and articles containing studies
and case reports of people with CNS tumor and depressive disorders that occurred either
before diagnosis or at any time during the course of the disease were selected
Abbreviated description of the state of knowledge
CNS tumors produce symptoms such as epilepsy, visual disturbances, paresis, but also
behavioral disorders. This is determined by the location of the tumor. Depression is a mental
disorder manifested mainly by lowered mood. This disorder can coexist with tumors
occurring in the frontal lobe or be present regardless of the location of the tumor, in people
diagnosed with a tumor with a poor prognosis.
Summary
Analyzing the selected articles, we see that in people who were diagnosed with a tumor
located in the frontal lobe, often the first symptom was depressive disorders, which even
preceded neurological symptoms. When depression is diagnosed, appearing suddenly and
refractory to treatment, one should consider whether there is an underlying pathological
lesion in the CNS. Unfortunately, there are no specific guidelines for imaging studies in
depressive disorders. People who suffer from malignant tumors with a poor prognosis should
be cared for by a psychologist, because as the disease progresses, the symptoms worsen,
affecting the prognosis.
References
Ghandour F, Squassina A, Karaky R, Diab-Assaf M, Fadda P, Pisanu C. Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review. Brain Sci. 2021 Feb 27;11(3):301. doi: 10.3390/brainsci11030301
Leo RJ, Frodey JN, Ruggieri ML. Subtle neuropsychiatric symptoms of glioblastoma multiforme misdiagnosed as depression. BMJ Case Rep. 2020 Mar 17;13(3). doi: 10.1136/bcr-2019-233208
Li Y, Jin Y, Wu D, Zhang L. A depression network caused by brain tumours. Brain Struct Funct. 2022 Nov;227(8):2787-2795. doi: 10.1007/s00429-022-02573-z. Epub 2022 Oct 3.
Munjal S, Pahlajani S, Baxi A, Ferrando S. Delayed Diagnosis of Glioblastoma Multiforme Presenting With Atypical Psychiatric Symptoms. Prim Care Companion CNS Disord. 2016 Dec 29;18(6).
Horbinski C, Ligon KL, Brastianos P, Huse JT, Venere M, Chang S, Buckner J, Cloughesy T, Jenkins RB, Giannini C, Stupp R, Nabors LB, Wen PY, Aldape KJ, Lukas RV, Galanis E, Eberhart CG, Brat DJ, Sarkaria JN. The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients. Neuro Oncol. 2019 Dec 17;21(12):1498-1508. doi: 10.1093/neuonc/noz119.
Nazlı ŞB, Sevindik M. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma. Turk Psikiyatri Derg. 2022 Summer;33(2):143-145. English, Turkish. doi: 10.5080/u25957.
Valko PO, Siddique A, Linsenmeier C, Zaugg K, Held U, Hofer S. Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro Oncol. 2015 Feb;17(2):274-81. doi: 10.1093/neuonc/nou127. Epub 2014 Jul 8. PMID: 25006033;
Fink JR, Muzi M, Peck M, Krohn KA. Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging. J Nucl Med. 2015 Oct;56(10):1554-61. doi: 10.2967/jnumed.113.131516.
Li Z, Ruan M, Chen J, Fang Y. Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications. Neurosci Bull. 2021 Jun;37(6):863-880. doi: 10.1007/s12264-021-00638-3.
Finze A, Deleanu L, Weiss C, Ratliff M, Seiz-Rosenhagen M. Depression in brain tumor patients-early detection and screening. Support Care Cancer. 2023 May 16;31(6):339. doi: 10.1007/s00520-023-07785-5.
Fu X, Wu C, Han N, Liu N, Han S, Liu X, Li S, Yan C. Depressive and anxiety disorders worsen the prognosis of glioblastoma. Aging (Albany NY). 2020 Oct 28;12(20):20095-20110. doi: 10.18632/aging.103593.
Wu X, Wang D, Wang D. Risk factors, prognostic potency, and longitudinal variation of anxiety and depression in postoperative glioma patients. Front Surg. 2023 Jan 16;9:1069709. doi: 10.3389/fsurg.2022.1069709.
Ferreira LP, Pinheiro CF, Fernandes NA, Ferreira CN. When Depression Hides a Brain Tumor: A Case of Glioblastoma. Prim Care Companion CNS Disord. 2019 Nov 14;21(6). 19l02455. doi: 10.4088/PCC.19l02455.
Petzold J, Severus E, Meyer S, Bauer M, Daubner D, Krex D, Juratli TA. Glioblastoma multiforme presenting as postpartum depression: a case report. J Med Case Rep. 2018 Dec 20;12(1):374. doi: 10.1186/s13256-018-1909-3.
Sharma A, Das AK, Jain A, Purohit DK, Solanki RK, Gupta A. Study of Association of Various Psychiatric Disorders in Brain Tumors. Asian J Neurosurg. 2022 Oct 28;17(4):621-630. doi: 10.1055/s-0042-1757437
Bommakanti K, Gaddamanugu P, Alladi S, Purohit AK, Chadalawadi SK, Mekala S, Somayajula S. Pre-operative and post-operative psychiatric manifestations in patients with supratentorial meningiomas. Clin Neurol Neurosurg. 2016 Aug;147:24-9. doi: 10.1016/j.clineuro.2016.05.018.
Dautricourt S, Marzloff V, Dollfus S. Meningiomatosis revealed by a major depressive syndrome. BMJ Case Rep. 2015 Dec 20;2015: bcr2015211909. doi: 10.1136/bcr-2015-211909.
Fraile-Martinez O, Alvarez-Mon MA, Garcia-Montero C, Pekarek L, Guijarro LG, Lahera G, Saez MA, Monserrat J, Motogo D, Quintero J, Alvarez-Mon M, Ortega MA. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine. Front Oncol. 2022 Sep 16;12:956923. doi: 10.3389/fonc.2022.956923.
Stöckelmaier L, Renovanz M, König J, Nickel K, Hickmann AK, Mayer-Steinacker R, Nadji-Ohl M, Ganslandt O, Bullinger L, Wirtz CR, Coburger J. Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life. World Neurosurg. 2017 Jun;102:383-399. doi: 10.1016/j.wneu.2017.02.061.
Ståhl P, Fekete B, Henoch I, Smits A, Jakola AS, Rydenhag B, Ozanne A. Health-related quality of life and emotional well-being in patients with glioblastoma and their relatives. J Neurooncol. 2020 Sep;149(2):347-356. doi: 10.1007/s11060-020-03614-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Klaudia Antkowiak, Hubert Ciecierski-Koźlarek , Urszula Żurek, Ignacy Tołwiński, Zofia Kędzierska, Klaudia Dadas, Aleksandra Świercz, Dominika Małachowska, Kateryna Shved

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 457
Number of citations: 0